Ultrasound-Tuned Antimicrobial Hydrogel–Coated Urinary Catheters Reduce Catheter-Associated Urinary Tract Infection: A Randomized Controlled Trial
Abstract
Background: Catheter-associated urinary tract infection remains a frequent healthcare-associated infection, largely driven by microbial adhesion and biofilm formation on catheter surfaces. Conventional antimicrobial coatings have shown inconsistent effectiveness because of passive release kinetics and declining activity over time. Objective: To compare catheter-associated urinary tract infection rates between ultrasound-tuned antimicrobial hydrogel–coated urinary catheters and standard uncoated silicone catheters. Methods: This prospective parallel-group randomized controlled trial enrolled 60 hospitalized adults requiring indwelling urinary catheterization for at least 72 hours. Participants were allocated equally to an ultrasound-tuned antimicrobial hydrogel–coated catheter group or a standard catheter group. The intervention group received daily low-intensity ultrasound activation, while both groups received standardized catheter care. The primary outcome was clinically assessed and microbiologically confirmed catheter-associated urinary tract infection. Secondary outcomes included urine colony count, time to infection onset, symptomatic infection, and adverse events. Results: Catheter-associated urinary tract infection occurred in 1/30 participants (3.3%) in the ultrasound-tuned hydrogel group and 5/30 participants (16.7%) in the standard catheter group, representing an absolute risk reduction of 13.4 percentage points and an estimated relative risk of 0.20. Mean urine…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 60 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.